Persistent infection of hepatitis C virus (HCV) can lead to liver cirrhosis and hepatocellular carcinoma, which are currently diagnosed by invasive liver biopsy. Approximately 15-20 % of cases of chronic liver diseases in India are caused by HCV infection. In North India, genotype 3 is predominant, whereas genotype 1 is predominant in southern parts of India. The aim of this study was to identify differentially regulated serum proteins in HCV-infected Indian patients (genotypes 1 and 3) using a two-dimensional electrophoresis approach. We identified eight differentially expressed proteins by MS. Expression levels of one of the highly upregulated proteins, retinolbinding protein 4 (RBP4), was validated by ELISA and Western blotting in two independent cohorts. We also confirmed our observation in the JFH1 infectious cell culture system. Interestingly, the HCV core protein enhanced RBP4 levels and partial knockdown of RBP4 had a positive impact on HCV replication, suggesting a possible role for this cellular protein in regulating HCV infection. Analysis of RBP4-interacting partners using a bioinformatic approach revealed novel insights into the possible involvement of RBP4 in HCV-induced pathogenesis. Taken together, this study provided information on the proteome profile of the HCV-infected Indian population, and revealed a link between HCV infection, RBP4 and insulin resistance.
INTRODUCTION
Hepatitis C virus (HCV) infection is one of the most common chronic infections in the world. Approximately 175 million individuals are infected with HCV and 3-4 million persons are newly infected each year (Soriano et al., 2009) . Previous studies have shown that~80 % of cases of acute hepatitis C progress to chronic infection and 10-20 % of them eventually develop chronic liver diseases, such as cirrhosis (Lavanchy, 2011) . This creates a potential threat for public health in the near future. Phylogenetic analyses of full-length or partial sequences of different HCV strains have shown the existence of six major genotypes and a large number of subtypes (Simmonds et al., 2005 (Simmonds et al., , 1993 . HCV genotyping revealed that the distribution of HCV genotypes varies in different geographical regions. Genotypes 1-3 are generally distributed throughout the world. Subtype 1a is abundant in North and South America, and Australia, whereas subtype 1b is found in Europe and many parts of Asia (Ramia & Eid-Fares, 2006; Zarkesh-Esfahani et al., 2010) . Approximately 15-20 % cases of chronic liver disease in India are caused by HCV. HCV genotypes show differing prevalence in different geographical regions in India. In northern parts of India, genotype 3 is the predominant genotype, whereas southern parts of India has a high occurrence of genotype 1 followed by genotype 3 (Valliammai et al., 1995; Panigrahi et al., 1996; Chowdhury et al., 2003; Raghuraman et al., 2003; Hissar et al., 2006) .
Blood is the most desirable source of biomarkers, primarily due to its ready accessibility. With proteomic tools developed recently, profiling of human plasma and the serum proteome has become more feasible in the search for disease-related markers, and understanding disease pathogenesis and the host immune response (Chen et al., 2004; Albuquerque et al., 2009; Rukmangadachar et al., 2011; Srivastava et al., 2012) . Among different proteomic technologies, two-dimensional gel electrophoresis (2DE) is considered as the most versatile method for separating proteins. This approach allows the investigation of protein expression changes, by differential and comparative proteomics, associated with the different pathological states of a biological system (Simula et al., 2012) . Many studies have suggested that efficient depletion of abundant proteins (albumin and IgG) from human serum enables detection of more proteins with greater protein coverage and high sensitivity (Chen et al., 2005) .
Several studies have shown the differential expression of many proteins and identified novel candidate serum biomarkers for liver fibrosis, cirrhosis or HCC (White et al., 2007; Gangadharan et al., 2007; Cheung et al., 2009; Gangadharan et al., 2012) . However, to the best of our knowledge, none of the studies have focused on the alterations in the serum proteome profile in Indian patients during HCV infection. In the present study, for the first time, we carried out a 2DE-based proteomic analysis, and identified differentially regulated proteins in the serum of Indian patients infected with HCV genotypes 1 and 3. We identified eight such proteins and validated one of the proteins, retinol-binding protein 4 (RBP4), which showed significant upregulation in HCVinfected serum samples compared with healthy controls. Further, we also used the JFH1 infectious cell culture system to confirm our observations. Additionally, we used bioinformatic approaches to identify the putative targets of RBP4.
RESULTS

Serum proteome profile of HCV-infected patients
To analyse the proteome profile in sera of HCV-infected patients, IgG-and albumin-depleted serum samples derived from healthy normal individuals (n55) and HCVinfected patients, genotypes 1 (n512) and 3 (n512), were subjected to 2DE. The 2DE gels were stained and proteins were visualized by silver staining. In total, 55 protein spots were found to be differentially expressed using Image Master 2D Platinum version 7.0 software. However, on the basis of statistical significance we proceeded with eight spots. Out of the eight spots, six spots (1-6) were found to be upregulated and two spots (7 and 8) were found to be downregulated in HCV-infected patients compared with healthy individuals (Fig. 1) . Magnified images of all the eight spots depicting differential levels are shown in Fig. 2(a) .
Identification of differentially expressed proteins in HCV-infected patients
Comparative analysis of our protein profile with the plasma protein map in the SWISS-2DPAGE database and published literature, as well as the relative location and molecular mass of protein spots 1-8, suggested that they could be apolipoprotein A-IV, CD5 antigen-like (CD5L), complement 3, apolipoprotein A-I, RBP4, transthyretin, haptoglobin and haptoglobin precursor, respectively. Out of these, six proteins (apolipoprotein A-IV, CD5L, complement 3, apolipoprotein A-I, RBP4 and transthyretin) were 
P=0.0002 P=0.0021 P<0.0001 Fig. 3 . Validation of RBP4 upregulation. RBP4 upregulation observed by 2DE was validated using (a) ELISA from two independent cohorts and (b) Western blot analysis using anti-RBP4 antibody. C, Healthy control serum sample; Gt1 and Gt3, patient sera corresponding to genotypes 1 and 3, respectively. upregulated, whereas two proteins (haptoglobin 16.8 kDa and haptoglobin precursor 42 kDa) were downregulated. To identify and prove conclusively that these spots indeed represented the above-mentioned proteins, spots 1-8 were excised from the gel, subjected to in-gel digestion with trypsin and analysed by MALDI-TOF MS ( (Frese et al., 2003) . (f) RBP4 and PEPCK transcript levels in Huh7, Rep2a and JFH1 transfected cells were analysed by qRT-PCR. (g) For the experiment in (f), RBP4 protein levels were analysed by using anti-RBP4 antibody. Western blot analysis for core, NS3 and actin was also performed using respective antibodies. S1-S8, available in the online Supplementary Material). In HCV genotype 1, complement 3, apolipoprotein A-IV, CD5L, apolipoprotein A-I, RBP4 and transthyretin were upregulated in 9/12 (75 %), 10/12 (83.3 %), 10/12 (83.3 %), 10/12 (83.3 %), 11/12 (91.6 %) and 9/12 (75 %) cases, respectively, whereas in HCV genotype 3, they were upregulated in 6/12 (50 %), 7/12 (58.3 %), 8/12 (66.6 %), 6/12 (50 %), 10/12 (83.3 %) and 7/12 (58.3 %), respectively. However, haptoglobin and haptoglobin Hp2-a were downregulated in 10/12 (83.3 %) cases in genotype 1 and 9/12 (75 %) cases in genotype 3 when compared with healthy controls.
Elevation of RBP4 levels in sera from HCVinfected patients
As serum RBP4 was found to be upregulated in the maximum number of patients for both genotypes, we further validated its upregulation in serum samples obtained from two independent cohorts of patients from two Indian cities, Hyderabad and Kolkata, by ELISA using anti-RBP4 antibody. Our results showed clearly that sera derived from HCV-infected patients had significantly elevated levels of RBP4 compared with sera derived from normal healthy controls (Fig. 3a) . Western blot analysis also showed enhanced levels of RBP4 in HCV-infected serum samples (Fig. 3b ).
Upregulation of RBP4 levels in HCV-infected liver cells
As liver is the primary site of HCV infection, elevated levels of RBP4 in HCV-infected patient's serum would most probably originate from the liver. Therefore, we were interested to look at the levels of RBP4 in HCV-infected liver cells. To investigate this, Huh7.5 cells were transfected with full-length JFH1 RNA (Wakita et al., 2005) . At 36 and 48 h post-transfection, cells were harvested and Western blotting was performed. Our observations clearly suggested high levels of RBP4 in HCV-infected cells (Fig. 4a, b ).
HCV core protein upregulates RBP4 levels HCV structural protein core has been shown to induce different stresses in HCV-infected liver cells and cause differential changes in cellular protein expression (Okuda et al., 2002; Benali-Furet et al., 2005) . To investigate if RBP4 upregulation is mediated through core protein, we transfected Huh7 cells with a mammalian expression construct encoding core, and checked the levels of RBP4 transcripts and protein using quantitative reverse transcription (qRT)-PCR and Western blot analysis, respectively ( Fig. 4c, d ). Our observations clearly suggested a considerable upregulation of RBP4 levels in the presence of core protein. Apart from its hepatotropic characteristic, HCV infection can lead to the development of type 2 diabetes or insulin resistance (Amarapurkar & Patel, 2008; Mangia & Ripoli, 2013) . It is also well known that serum RBP4 contributes to insulin resistance and increases glucose output by elevating the expression of gluconeogenic enzymes, including phosphoenolpyruvate kinase (PEPCK) (Yang et al., 2005) . To investigate if core upregulation could increase PEPCK levels as well, we quantified the levels of PEPCK in the Huh7 cell line transiently expressing core protein (Fig. 4c) . Interestingly, we observed a significant upregulation of PEPCK mRNA levels, suggesting that HCV core protein might be important for the development of type 2 diabetes in HCV-infected patients. To further investigate whether viral non-structural (NS) proteins could also perform the same function, the Huh7 cell line expressing viral NS proteins (Rep2a cell line) (Frese et al., 2003) (Fig.  4e ) was used. We performed qRT-PCR analysis to detect Fig. 6 . Pathway analysis of differentially regulated serum proteins. The proteins that were found to be differentially regulated in the serum of HCV-infected patients, i.e. RBP4, complement C3, transthyretin, apolipoprotein A-I, apolipoprotein A-IV, CD5L and haptoglobin, were used to construct an interactome by STRING and Cytoscape. The connecting lines indicate direct/indirect interactions between proteins. The network depicts a convergence in the pathways regulated by the differentially regulated proteins in HCV infection identified in our study, which in concert would affect cellular metabolism and cell survival.
RBP4 and PEPCK mRNA levels (Fig. 4f ). Results showed no significant difference in RBP4 and PEPCK transcript levels between Huh 7 and Rep2a cell lines, suggesting that HCV NS proteins may not have any role in regulating RBP4 expression. A similar finding was observed for RBP4 protein levels (Fig. 4g) . In contrast, transfection of JFH1 RNA could increase both RBP4 and PEPCK expression ( Fig. 4f, g) . Moreover, as expected, the level of RBP4 was also found to be increased when core was expressed in the Rep2a cell line (Fig. S9) .
Effect of partial knockdown of RBP4 on HCV replication
To study whether RBP4 has any impact on HCV replication, we knocked down its expression by using small interfering RNA (siRBP4) in both HCV subgenomic replicon-harbouring cells (Rep2a) as well as HCV-JFH1transfected cells. Although there was no significant effect on HCV RNA levels in Rep2a cells, we noticed a significant increase in HCV RNA levels in JFH1-infected cells upon RBP4 knockdown (Fig. 5a, b ). This indicated that cellular RBP4 might have an inhibitory effect on HCV replication.
Interaction network of RBP4
In order to gain insights into the possible downstream effects of RBP4 upregulation, we identified its bio-association with other proteins by single-protein network analysis using STRING version 9.05 (Fig. S10 ). Different types of evidence for association, including neighbourhood, gene fusion, cooccurrence, coexpression, experimental, database, text mining and homology, were taken into account to determine this network of interactions. The networks were integrated and visualized using Cytoscape and Cyto-Hubba. The network revealed close associations between pathways regulated by RBP4 and most of the other proteins that were identified to be differentially regulated in the serum of infected patients in our study, indicating that these proteins might function in concert to deregulate lipid biosynthesis and glucose metabolism pathways in HCV infection (Fig. 6 ).
DISCUSSION
In this study, to analyse the alterations in the human serum proteome due to infection with HCV genotypes 1 and 3, we applied a 2DE-based proteomic strategy for the detection of quantitative differences between proteins derived from the sera of these two groups. We identified the protein spots of interest that were present at significantly different levels in HCV genotype 1and 3 patients compared with healthy controls.
We identified eight differentially expressed proteins as potential candidates associated with HCV infection in both genotypes. Of them, some were demonstrated to be related to HCV infection in previous studies, e.g. CD5L was reported to be upregulated in hepatitis C patients with cirrhosis (Gangadharan et al., 2007) . In our study, we also observed the upregulation of this protein in both genotypes, although the upregulation was found in more cases of infection by HCV genotype 1 as compared with genotype 3. This gave us an idea that genotype specificity might also be an essential criterion contributing to the differential expression levels of several cellular proteins that influence the extent of pathogenesis. Previous studies have shown the downregulation of apolipoprotein A-I and apolipoprotein A-IV in HCV-infected liver fibrosis (White et al., 2007) . However, in our study, we found these proteins to be upregulated in both genotypes. It is possible that expression levels of apolipoprotein A-I and apolipoprotein A-IV might fluctuate in different stages of HCV infection. Haptoglobin levels have been observed to be low in liver fibrosis in hepatitis C patients (Cheung et al., 2009; Gangadharan et al., 2012) . In our study, we also observed the downregulation of haptoglobin for both genotypes.
RBP4 is an adipocytokine (Yang et al., 2005) belonging to the proteins of the lipocalin family and transports retinol from the liver to peripheral tissues. The relationship of RBP4 with insulin resistance and type 2 diabetes is still controversial (Janke et al., 2006; Broch et al., 2007; Yagmur et al., 2007; Yao-Borengasser et al., 2007; Huang et al., 2009; Kotnik et al., 2011) . Epidemiological studies demonstrated an increased occurrence of metabolic disorders such as insulin resistance and steatosis in patients with HCV infection. In such patients, insulin resistance may have several harmful consequences, including faster progression of liver fibrosis, resistance to anti-HCV therapy and development of HCC (Mangia & Ripoli, 2013) . The observations by Alkhouri et al. (2009) and Qin et al. (2012) demonstrated an inverse correlation between RBP4 levels and the stage of fibrosis, suggesting RBP4 as a potential marker to determine the progression of fibrosis. Another study showed higher serum RBP4 levels in non-diabetic genotype 1-infected chronic hepatitis C patients with steatosis than in nonalcoholic fatty liver disease, suggesting an independent association of RBP4 with steatosis that was largely unrelated to insulin resistance (Petta et al., 2008) .
In this study, we provide a link between HCV and insulin resistance by upregulation of RBP4 expression. We have highlighted that HCV core-mediated induction of RBP4 levels might be responsible for establishing insulin resistance, as observed by increased expression of one of the glucogenogenic genes, PEPCK, during HCV infection. HCV core protein might lead to insulin resistance by promoting proteosomal degradation of insulin receptor substrates and interfering with insulin signalling. The latter is mediated by inducing the expression of TNF-a and SOCS3 (suppressor of cytokine signalling 3), which may contribute to the development of steatosis (Biddinger & Kahn, 2006; El-Zayadi & Anis, 2012 is well known that RBP4 regulates the insulin receptor signalling pathway and thus gluconeogenesis as well as lipogenesis. Knockdown of RBP4 activates the mTORC1 (mammalian target of rapamycin complex 1) pathway leading to increased SREBP-1 (sterol regulatory elementbinding protein 1) levels and thus lipogenesis (Xia et al., 2013) . As formation of lipid rafts is critical for HCV replication and assembly, RBP4 knockdown might be advantageous for the virus. However, it is also clear from our study that viral infection upregulates RBP4. This could either be a host defence strategy to counter viral attack or a viral strategy to maintain its replication at an optimal level so as to establish chronicity in the cells.
Furthermore, our study with the interaction network revealed apolipoprotein A-I, a 1 -microglobulin/bikunin precursor (AMBP), cytochrome P2C9 (CYP2C9), etc., as plausible interacting partners of RBP4. An association of HCV NS5A and core with apolipoprotein A-I in lipid droplets is known (Shi et al., 2002) . It is possible that RBP4 might be part of this lipid complex by interacting with apolipoprotein A-I and thus contributing to liver steatosis. Gene expression profiling, using expressed sequence tags, showed the downregulation of AMBP expression levels in HCV-associated HCC cells (Yoon et al., 2006) . Our study indicates that RBP4 might act as a negative regulator of AMBP expression. c-Myc-related production of reactive oxygen species in the presence of HCV proteins has been associated with the transcriptional deregulation of CYP2C9 (Higgs et al., 2012) . CYP2C9 expression was found to be significantly higher in HCV-infected patients compared with non-HCV-infected patients. It is possible that RBP4 interaction with CYP2C9 might contribute to viral persistence in HCC patients. In addition, from the interactome, we observed that the differentially regulated proteins identified in our study (RBP4, apolipoprotein A-I, apolipoprotein A-IV, transthyretin, CD5L and haptoglobin) are all part of closely linked pathways, which is in accordance with the literature. RBP4, CD5L, haptoglobin and transthyretin were among the top ranking nodes of the network as indicated by Cyto-Hubba. Among them, RBP4, transthyretin, haptoglobin, apolipoprotein A-I and apolipoprotein A-IV [components of high-density lipoprotein (HDL)] are all known to be associated with one another in the serum and influence serum HDL levels as well as cholesterol uptake. Both RBP4 and transthyretin transport retinol from the liver to the peripheral tissues, where the retinoic acid receptors are activated. Activation of this pathway stimulates gluconeogenesis, inhibits lipogenesis and also inhibits apoptosis by induction of CD5L (Shea et al., 2010; Zelcer & Tontonoz, 2006) . Thus, our study identifies a set of differentially regulated proteins that together influence lipid metabolism and apoptosis in HCV infection, and provides clues for further investigation of the pathways involved.
Taken together, our study reveals a protein signature, as potential biomarkers that would ultimately help clinicians in prognosis of HCV infection. This highlights the induction of RBP4 by HCV core protein as a possible lead to insulin resistance and the role of RBP4 as a regulator of HCV infection. Thus, the study provides an important insight into the mechanisms of viral pathogenesis and host cell response during HCV infection. Biosciences) and analysed by using ImageMaster 2D Platinum software (Amersham Biosciences).
METHODS
In-gel digestion. Protein spots of interest were excised manually from the gels, minced into 1 mm 3 pieces with the help of a sterile scalpel and transferred to 1.5 ml microcentrifuge tubes. The gel pieces were washed three times with 500 ml wash solution (15 mM potassium ferricyanide and 50 mM ammonium bicarbonate for 15 min each) until the silver stain had been removed completely. Proteins in the gel pieces were reduced and alkylated with 10 mM DTT (30 min at 56 uC) and 50 mM iodoacetamide (30 min at room temperature in the dark), respectively. Digestion was carried out with 500 ng trypsin in 50 mM ammonium bicarbonate buffer overnight. After overnight digestion, samples were briefly centrifuged and the supernatant (containing tryptic peptides) was transferred to a sterile centrifuge tube. Further extraction of peptides was performed using an additional 20-25 ml extraction solution (60 % acetonitrile, 0.1 % TFA), drying the pooled extracted peptides by centrifugal evaporation to near dryness and resuspending the sample by adding 5 ml resuspension solution (50 % acetonitrile, 0.1 % TFA) suitable for MALDI-TOF analysis.
MALDI-TOF MS and protein identification. An aliquot of 1 ml peptide solution was mixed with an equal volume of matrix solution (R-cyano-4-hydroxycinnamic acid or 2.5-dihydroxybenzoic acid), spotted on the MALDI plate and air-dried at room temperature prior to acquiring mass spectra. MALDI-TOF MS analysis was carried out on an ultraflex TOF/TOF (Bruker Daltonics) and the peptide mass spectrum was acquired in the reflectron mode. The monoisotopic mass list was generated using the smoothing function in Flex Analysis 2.0 software. Trypsin autolysis products and keratin-derived peaks were excluded from the peak list. The monoisotopic masses from the spectrum were used for protein identification using the search engine MASCOT v2.2 (www.matrixscience.com). The search parameters were: peptide tolerance, 0.5-1 Da; species, Homo sapiens. Maximum number of missed cleavages was set to 1. Carbamidomethyl was considered as a fixed modification for cysteine by iodoacetamide.
Oxidation of methionine was taken as a variable modification during the database search.
ELISA. Nunc 96-well microtitre plates were coated overnight with serum followed by blocking of unoccupied sites with 0.5 % (w/v) gelatin in PBS. Incubation was done with anti-RBP4 antibody (Sigma) for 2 h at room temperature followed by washing with PBS containing 0.05 % Tween-20. Plates were incubated with HRPconjugated secondary antibody (Sigma) for 1 h at room temperature. The reaction was detected using tetramethylbenzidine and 0.03 % H 2 O 2 , and stopped with 1 M H 2 SO 4 . OD 450 was measured in an ELISA plate reader (Spectramax; Molecular Devices). Statistical significance of the data was determined by using the non-parametric Mann-Whitney test.
Cell culture. Cell lines were maintained at 37 uC in 5 % CO 2 in Dulbecco's modified Eagle's medium (DMEM, Sigma) supplemented with 10 % heat-inactivated FBS, 100 mg streptomycin sulphate ml 21 and 100 U penicillin ml 21 (DMEM-complete).
In vitro transcription of JFH1 RNA. The pJFH1 construct (a generous gift from Dr Takaji Wakita) was linearized with XbaI restriction enzyme. HCV JFH1 RNA was in vitro transcribed from the linearized DNA template by using the T7-based RiboMAX large-scale RNA production system according to manufacturer's instructions (Promega).
Transient transfection. Huh7.5 cells were transiently transfected with HCV-JFH1 RNA using Lipofectamine 2000 reagent (Invitrogen) in an antibiotic-free medium. The cells were harvested using TRI Reagent (Sigma) and total cellular RNA was extracted followed by qRT-PCR. Non-specific siRNA and siRBP4 (Dharmacon) were used for transfections.
qRT-PCR. Total cellular RNA (2 mg) was reverse transcribed for cDNA synthesis by using RevertAid Moloney murine leukaemia virus reverse transcriptase (Thermo Scientific). cDNA (1 : 10 diluted) was amplified using the DyNAmo SYBR Green real-time assay mixture (Thermo Scientific) as per the manufacturer's instructions.
Western blot analysis. Protein samples, including sera and cell lysates, were separated by 12 % SDS-PAGE and then transferred onto nitrocellulose membranes (PALL Life Sciences) by the semi-dry Western blotting method (Bio-Rad). Analysis was performed using rabbit anti-RBP4 antibody (Sigma) followed by HRP-conjugated antirabbit secondary antibody (Sigma). Anti-b-actin peroxidase antibody (Sigma) was used to detect actin as an internal control for normalizing loading of cellular lysates. The blots were developed by chemiluminescence using an enhanced chemiluminescence detection system.
